Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Delgado

Showing results (271-280 of 289) with videos related to

Pageof 29
Sort By:
Lancet (London, England)|May 7, 2022
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trialJavier Delgado-Lista, Juan F Alcala-Diaz, Jose D Torres-Peña, et al.
Leukemia|April 1, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapyGloria Iacoboni, Kai Rejeski, Víctor Navarro, et al.
Blood Advances|July 30, 2025
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkersTeresa Caballero-Velázquez, Javier Delgado-Serrano, Lucia López-Corral, et al.
Frontiers in Immunology|August 1, 2022
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish GroupsMariana Bastos-Oreiro, Antonio Gutierrez, Juan Luís Reguera, et al.
Frontiers in Immunology|May 1, 2023
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignanciesClara Beatriz García-Calderón, Belén Sierro-Martínez, Estefanía García-Guerrero, et al.
Journal of Clinical Lipidology|September 29, 2016
Assessment of postprandial triglycerides in clinical practice: Validation in a general population and coronary heart disease patientsPablo Perez-Martinez, Juan F Alcala-Diaz, Edmon K Kabagambe, et al.
Transplantation and Cellular Therapy|July 28, 2024
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMORebeca Bailén, Gloria Iacoboni, Javier Delgado, et al.
Haematologica|June 30, 2022
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphomaMi Kwon, Gloria Iacoboni, Juan Luis Reguera, et al.
Journal of Hematology & Oncology|October 29, 2024
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatmentGloria Iacoboni, Víctor Navarro, Pierre Sesques, et al.
Hemasphere|May 22, 2024
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapyGloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, et al.
Pageof 29

Showing results (271-280 of 289) with videos related to

Sort By:
Pageof 29
Lancet (London, England)|May 7, 2022
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trialJavier Delgado-Lista, Juan F Alcala-Diaz, Jose D Torres-Peña, et al.
Leukemia|April 1, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapyGloria Iacoboni, Kai Rejeski, Víctor Navarro, et al.
Blood Advances|July 30, 2025
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkersTeresa Caballero-Velázquez, Javier Delgado-Serrano, Lucia López-Corral, et al.
Frontiers in Immunology|August 1, 2022
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish GroupsMariana Bastos-Oreiro, Antonio Gutierrez, Juan Luís Reguera, et al.
Frontiers in Immunology|May 1, 2023
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignanciesClara Beatriz García-Calderón, Belén Sierro-Martínez, Estefanía García-Guerrero, et al.
Journal of Clinical Lipidology|September 29, 2016
Assessment of postprandial triglycerides in clinical practice: Validation in a general population and coronary heart disease patientsPablo Perez-Martinez, Juan F Alcala-Diaz, Edmon K Kabagambe, et al.
Transplantation and Cellular Therapy|July 28, 2024
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMORebeca Bailén, Gloria Iacoboni, Javier Delgado, et al.
Haematologica|June 30, 2022
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphomaMi Kwon, Gloria Iacoboni, Juan Luis Reguera, et al.
Journal of Hematology & Oncology|October 29, 2024
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatmentGloria Iacoboni, Víctor Navarro, Pierre Sesques, et al.
Hemasphere|May 22, 2024
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapyGloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, et al.
Pageof 29